Edison, NJ and Hamburg, Germany 7/11/07—Eppendorf AG has agreed to acquire New Brunswick Scientific for approximately $110 million. Eppendorf will acquire the outstanding common stock for $11.50 per share, a 43% premium over the July 10 closing price, and will settle all outstanding stock options for cash. New Brunswick Scientific will become a subsidiary of […]

In 2006, the German Research Foundation (DFG) had €1.41 billion ($1.76 billion) in income, according to the foundation’s annual report. Of this income, 58.2% came from the national government, 41.0% from local government and 0.4% from foundations and private companies. In the first round of the Excellence Initiative, 18 graduate schools, 17 clusters of excellence […]

First quarter revenues for the IBO Lab Equipment/Consumables Index jumped 12.4% to $799 million. Operating profits improved 25.6% to $232 million, and operating margin climbed 310 basis points to 29.0% of sales. Fisher Scientific’s merger with Thermo Electron had a significant impact on the revenue and operating growth for the Index (see IBO 5/15/06). Fourteen […]

SGE Analytical Services signed a joint R&D agreement with the Australian Proteome Facility for applications of its ProteCol LC platform and microfabrication technologies for protein biomarker discovery. Waters entered into a Cooperative Research and Development Agreement with the EPA’s National Exposure Research Laboratory to develop trace level analytical methods for detecting perfluorinated compounds in soil […]

R&D spending by analytical and life science instrument companies showed a robust increase last year, according to IBO’s annual survey of R&D spending, indicating healthy business conditions and an optimistic forecast among instrument companies. In fact, several companies, both large and small, made sizable increases to R&D. R&D spending by the 15 instrument companies surveyed […]

Numerous countries are funding national nanotechnology efforts in order to develop the R&D and infrastructure capabilities to support private and public opportunities in nanotech technologies and products in fields ranging from medicine, to semiconductors, to chemicals. At stake is industrial and scientific leadership in a new field whose potential impact has been compared to biotechnology […]

Tecan elected Heinrich Fischer, former CEO of the Saurer Group, and Jürg Meier, former head of the Novartis Venture Fund, to its board, replacing Heino von Prondzynski, who resigned, and Timothy Anderson. The April election defeated candidates and motions put forward by BB Medtech, the company’s largest shareholder. NanoString Technologies is developing with Applied Precision […]

St. Louis, MS and Richmond, CA 7/10/07—Sigma-Aldrich has licensed Sangamo BioSciences’ zinc finder DNA-binding proteins (ZFPs) for development of research reagents for the regulation of gene expression in living cells. Sigma-Aldrich also acquired rights to sublicense the technology for research applications. Sigma-Aldrich will initially pay Sangamo $13.75 million in the form of an upfront licensing […]